FDA Warning Letter — B. Braun US Pharmaceutical Manufacturing, LLC
The FDA took a Warning Letter action against B. Braun US Pharmaceutical Manufacturing, LLC on May 12, 2017 (Irvine, CA). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- B. Braun US Pharmaceutical Manufacturing, LLC
- Date
- May 12, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Irvine, CA (United States)